Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps

    Screening tests for detecting open angle glaucoma: a systematic review and meta-analysis

    Methodological quality of the review: Medium confidence

    Author: Mowatt G, Burr JM, Cook JA, Siddiqui MA, Ramsay C, Fraser C, Azuara-Blanco A, Deeks JJ; OAG Screening Project

    Geographical coverage: United States of America (USA), Canada, Spain, Italy, Greece, Sweden, Australia, United Kingdom (UK), Norway, India, Netherlands, Belgium

    Sector: Glaucoma

    Sub-sector: Open angle glaucoma

    Equity focus: None specified

    Review type: Systematic review

    Quantitative synthesis method: Meta-analysis

    Qualitative synthesis method: Not applicable

    Background: Early detection and diagnosis of glaucoma, especially open angle, will delay disease progression and blindness. There are many tests or combinations of tests for detecting glaucoma, and it is very important to identify the optimal test or combination of tests.

    Objectives : To assess the comparative accuracy of potential screening tests for open angle glaucoma (OAG).

    Main findings: 40 studies enrolling over 48,000 people reported nine tests were included. 20 studies were population-based and representative of a screening setting, whereas 20 studies were considered representative of patients with suspected glaucoma referred from primary care, of which eight were cohort studies and 12 were case-control studies. Seven studies used the first and best reference standard of open-angle glaucoma (OAG) confirmed on longitudinal follow-up, whereas the remainder used ophthalmologist-diagnosed OAG.

    Frequency-doubling technology (FDT; C-20-1) was significantly more sensitive than ophthalmoscopy (30, 95% credible interval [CrI] 0–62) and Goldmann applanation tonometry (GAT; 45, 95% CrI 17–68), whereas threshold standard automated perimetry (SAP) and Heidelberg Retinal Tomograph (HRT II) were both more sensitive than GAT (41, 95% CrI 14–64 and 39, 95% CrI 3–64, respectively).

    GAT was more specific than both FDT C-20-5 (19, 95% CrI 0-53) and threshold SAP (14, 95% CrI 1-37). Judging performance by diagnostic odds ratio, FDT, oculokinetic perimetry and HRT II are promising tests. Ophthalmoscopy, SAP, retinal photography and GAT had relatively poor performance as single tests. The interpretation of these findings should take into account heterogeneity and the limited quality of the data, and the consequent associated considerable uncertainty.

    The authors concluded that there was no specific test or group of tests clearly superior for glaucoma screening. Further research is needed to evaluate the comparative accuracy of the most promising tests.

    Methodology: The following databases were used for this review: MEDLINE, EMBASE, Biosis, Science Citation Index and the Cochrane Library. In addition, full-text electronic searches of the American Journal of Ophthalmology, British Journal of Ophthalmology, Investigative Ophthalmology and Visual Science, and the Journal of Glaucoma were undertaken. Searches were restricted to English language publications. To identify additional potentially relevant reports, the reference lists of included studies were also scanned. Studies assessing candidate screening tests for detecting OAG in persons older than 40 years that reported true and false positives and negatives were included.

    Two reviewers extracted the data from identified studies in a single form. In the event of uncertainty, the other reviewer provided advice and validated the data extraction. Quality assessment was done by two reviewers independently using a version of QUADAS adapted for assessing reports of the accuracy of screening tests for OAG. QUADAS is a quality-assessment tool for use in systematic reviews of diagnostic studies. Disagreements were resolved by consensus or arbitration by a third reviewer.

    Meta-analysis was undertaken using the hierarchical summary receiver-operating characteristic model.

    Applicability/external validity: Authors did not discuss the applicability/external validity of the results

    Geographic focus: This review did not focus specifically on low/middle-income countries. However, data from Spain and Greece were presented. In the context of this assessment, conclusions and outcomes will benefit low/middle-income countries.

     

    Summary of quality assessment: Authors conducted comprehensive searches to identify relevant studies. However, language bias was not avoided, as only English articles were included. Two researchers examined the title and abstract of each paper; however, it is not clear if this was done independently or not. Overall, the method used to analyse findings is clearly reported, and limitations are appropriately acknowledged by the reviewers. Thus, medium confidence was attributed to the conclusion about the effects of this review.

    Publication source: Mowatt G, Burr JM, Cook JA, Siddiqui MA, Ramsay C, Fraser C, Azuara-Blanco A, Deeks JJ; OAG Screening Project. Screening tests for detecting open angle glaucoma: systematic review and meta-analysis. Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5373-85 Source
    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.